vimarsana.com

Page 2 - கனடியன் சங்கம் ஆஃப் மருந்தகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The COVID REPORT – stay at home, local numbers and more …

State of emergency – stay at home orders implemented The Ontario government, in consultation with the Chief Medical Officer of Health and other health experts, is immediately declaring a third provincial state of emergency under the Emergency Management and Civil Protection Act. These measures are being taken in response to the rapid increase in COVID-19 transmission, the threat on the province’s hospital system capacity, and the increasing risks posed to the public by COVID-19 variants. Case rates, hospitalizations, and ICU occupancy are increasing rapidly, threatening to overwhelm the health care system. The province-wide Stay-at-Home order, which came into effect at midnight, requires everyone to remain at home except for essential purposes, such as going to the grocery store or pharmacy, accessing health care services (including getting vaccinated), outdoor exercise, or for work that cannot be done remotely.

Cancer patients could be at risk if second doses delayed beyond three weeks, oncologists say

  TORONTO Oncologists are ringing the alarm bell over the prevailing policy of delaying the second dose of the vaccine for up to four months, saying this strategy could leave cancer patients unprotected. Citing preliminary research from the U.K., the Canadian Association of Pharmacy in Oncology (CAPhO) said in a statement Wednesday that cancer patients are significantly less protected by a single dose of the Pfizer-BioNTech vaccine than the general public. “The study shows that three weeks after one dose of the vaccine an immune response was found in 39 per cent of people with a solid cancer and just 13 per cent of people with blood cancer,” Tina Crosbie, President of CAPhO, said in the statement. “An antibody response was found in 97 per cent of the healthy volunteers tested.”

Cancer patients could be at risk if second doses delayed beyond three weeks, experts say

  TORONTO Experts are ringing the alarm bell over the prevailing policy of delaying the second dose of the vaccine for up to four months, saying this strategy could leave cancer patients unprotected. Citing preliminary research from the U.K., the Canadian Association of Pharmacy in Oncology (CAPhO) said in a statement Wednesday that cancer patients are significantly less protected by a single dose of the Pfizer-BioNTech vaccine than the general public. “The study shows that three weeks after one dose of the vaccine an immune response was found in 39 per cent of people with a solid cancer and just 13 per cent of people with blood cancer,” Tina Crosbie, President of CAPhO, said in the statement. “An antibody response was found in 97 per cent of the healthy volunteers tested.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.